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ABSTRACT 
Objective: Development and validation of new, simple and reliable enantioselective reverse phase ultra-fast liquid chromatography (RP-UFLC) 
method for quantification of chlorthalidone in bulk and pharmaceutical dosage form. 
Methods: In the present study, the isocratic RP-UFLC method was developed on Phenomenex® Lux cellulose 4 column (250×4.6 mm, 5µ) and di-
sodium hydrogen phosphate buffer (pH 3.6): methanol (40:60 v/v) as mobile phase. Elute was monitored at 240 nm with a flow rate of 1 ml/min.  
Results: The described method provided linear correlation (R2=0.999) between the range of 2-10 µg/ml. Chlorthalidone enantiomers showed good 
resolution with a retention time (tR) of 5.75 min and 7.46 min respectively. The precision of the method revealed that relative standard deviation is 
within the acceptable limit. The percentage recovery of each chlorthalidone enantiomers was found to be 99.98% and 100.09% respectively. The 
method was validated in accordance with ICH harmonized tripartite guidelines, validation of analytical procedures: text and methodology Q2 (R1). 
Conclusion: An economical, accurate, sensitive and precise RP-UFLC method was developed and fully validated for quality control analysis of 
chlorthalidone in pharmaceutical dosage form.  
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Chemically chlorthalidone is (RS) 2-chloro-5-(1-hydroxy-3oxo-2, 3-
dihydro-1H-isoindol-1-yl) benzene-1-sulfonamide [fig.1]. Chlorthalidone 
is an oral diuretic drug widely used for the treatment of 
hypertension. It is described as a thiazide-like diuretic because it 
acts similarly to the thiazides. While comparing with other 
medications of the thiazide class, chlorthalidone has the longest 
duration of action [1]. Chlorthalidone is practically insoluble in 
water, but it is soluble in methanol. Its molecular formula and the 
molecular weight is C14H11ClN2O4S and 338.766 g/mol respectively. 
It was also more effective than amlodipine in reducing congestive 
heart failure (CHF) in the antihypertensive and lipid-lowering 
treatments to prevent heart attach trial (ALLHAT) [2]. Furthermore, 
chlorthalidone prevents reabsorption of sodium and chloride by 
inhibiting the Na+/Cl− symporter in the distal convoluted tubule i.e.; 
it increases the rate of excretion of Na+and Cl from the body [3].  
 
 
Fig. 1: Chemical structure of chlorthalidone [4] 
 
The literature survey reveals numerous non-stereoselective 
analytical methods that have been developed for chlorthalidone in 
their bulk and pharmaceutical formulations. There were reports of 
ultraviolet spectroscopy [4], supercritical fluid chromatography [5], 
gas chromatography [6], reverse phase high-performance liquid 
chromatography (RP-HPLC)[7], Stability indicating RP-HPLC method 
[8], simultaneous estimations by RP-HPLC in pharmaceutical 
formulation [9, 10] and biological samples [11, 12]. Also 
stereoselective UFLC [13] method was developed for the same drug 
by using kromosil TBB (0, 0'-bis (4-tertbutylbenzoyl)-N, N'-diallyl-
Ltartardiamide) chiral column but the reported work was based on 
normal phase method (makes the method more expensive) and the 
method is less sensitive. The chief objective of the current work was 
to develop a simple, sensitive, stereoselective and economic method 
for quantitative determination of chlorthalidone in bulk and 
pharmaceutical dosage form. 
MATERIALS AND METHODS  
Solvents and chemicals 
Reference standard of racemic chlorthalidone was obtained from 
Hetero drugs Pvt. Ltd., Hyderabad, India and was used to develop 
the RP-UFLC method. HPLC grade methanol was obtained as of 
Merck specialities Pvt. Ltd., Mumbai, India. Other chemicals and 
reagents were of analytical grade. Millipore purification system 
(Direct-Q, Bangalore, India) was used to produce water for the RP-
UFLC method. Tablet CTD-12.5, IPCA Laboratories Ltd, India 
containing 12.5 mg of chlorthalidone IP was procured from the local 
pharmacy, Mysuru, Karnataka, India. 
Instrumentation 
A Shimadzu ultra fast liquid chromatography (Prominence LC-
20AD) equipped with prominence SIL-20ACHT autosampler, 1260 
binary pump VL (35MPa) and Shimadzu prominence SPD-M20A 
diode array detector were utilized. All another weighing for the 
analysis was accomplished on Shimadzu electronic analytical 
balance AY-220. Data collection and analysis were performed using 
LC solution Software. Quantification of chlorthalidone was achieved 
using Lux 5µ cellulose 4 column. The mobile phase was composed of 
Di-sodium hydrogen phosphate (Na2HPO4) buffer pH 3.6 and 
methanol in the ratio 40:60 v/v. The optimized chromatographic 
conditions are shown in table 1. 
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Table 1: Chromatographic conditions for the developed method 
Parameters Methods 
Stationary phase Lux cellulose 4 column(250×4.6 mm, 5µ) 
Mobile phase Na2HPO4 buffer pH 3.6: methanol (40:60 v/v) 
Flow rate (ml/min) 1.0 
Elution Isocratic 
Runtime (minutes) 10 
Column temperature ( °C) Ambient 
Volume of injection loop (μl) 10 
Detector PDA 
Detection wavelength (nm) 240 
Enantiomer 1 tR (min) 




Preparation of phosphate buffer pH 3.6 
0.900 g of anhydrous disodium hydrogen phosphate and 1.298 g of 
citric acid monohydrate was dissolved inadequate water to make 
1000 ml. The pH (3.6) of the resultant solution was adjusted with o-
phosphoric acid. Finally, the mobile phase was filtered through a 
membrane filter (0.45 μ) prior to use.  
Preparation of standard solution of racemic chlorthalidone 
Chlorthalidone (1000 μg/ml) standard stock solution was prepared by 
precisely weighing 50 mg in 50 ml volumetric flask, and the volume was 
made up with methanol. Taking appropriate aliquot from standard stock 
solution, 10µg/ml was prepared using the same solvent.  
Assay 
From the fine crushed tablet powder, an accurate quantity of 100 mg 
of powder was transferred into a 100 ml volumetric flask and 
diluted with methanol. The solution was filtered through 0.45μm 
membrane filter to remove undissolved particulates. The resulting 
stock solution was diluted further to obtain the concentration of 
4μg/ml. The mobile phase was equilibrated before 1 hr of the 
injection of the sample. The flow rate was set at 1.0 ml/min with the 
wavelength of 240 nm.  
Method validation 
The developed RP-UFLC method was validated as per ICH guidelines [14].  
Linearity and range 
The linearity of the method is an ability to get a test result which 
gives a clear mathematical relationship to the concentration 
(amount) of an analyte. A standard stock solution of chlorthalidone 
(1000 μg/ml) was prepared by dissolving precisely 50 mg of 
chlorthalidone in 50 ml volumetric flask and volume were made up 
with methanol. The stock solution was diluted further to obtain 2-
10μg/ml concentration range and all dilutions were prepared in 
triplicate. The peak areas, retention times, intercept and slope, were 
noted. 
Precision 
System precision and method precision was determined by means of 
repeatability (intraday) and intermediate precision (inter-day) studies 
by measuring the peak area and retention time of 3 different sets of each 
different concentration (2, 4 and 6 μg/ml) of chlorthalidone.  
Repeatability  
It was performed by repeated injections of 3 different 
concentrations from single batch under the same experimental 
conditions on the same day. % RSD for both retention time and peak 
area was calculated. 
Intermediate precision  
Intermediate precision of the method was evaluated by performing 
the same repeated study on the day after that for three different 
concentrations of chlorthalidone. From the results, % RSD values for 
mean retention time and mean peak area were calculated. 
System suitability tests 
Data obtained after giving six replicate injections of a standard 
solution (6μg/ml) of chlorthalidone were assessed. The peak areas, 
theoretical plates (N), resolution (Rs), tailing factor (T), capacity 
factor (k’) and asymmetric factor (As) were noted and calculated. 
Accuracy 
Accuracy assesses the closeness of the experimental value to that of 
the true value and was measured by standard addition method. 
Accuracy was implemented at three levels (50%, 100% and 150%) 
where known amount of standard was added to a pre-analyzed 
(fixed) sample formulation. The tests were carried out in triplicate. 
For all concentrations, the % RSD and % recovery were calculated. 
Sensitivity 
The sensitivity of the method can be measured from the limit of 
detection (LOD) and limit of quantification (LOQ). The LOD and LOQ 
can be calculated on the basis of response, i.e., the y-intercept of the 
regression line and slope of the calibration curve. The equation was 
given below, 
   
Where,  
σ = standard deviation of response (y-intercept of the regression line)  
S = slope of the calibration curve  
Robustness 
The consequence of the small but deliberate change of the 
chromatographic conditions was studied to assess the robustness of 
the method. Robustness can be measured by varying the organic 
solvent (60±5%), flow rate (1.0±0.1 ml/min), ionic strength of buffer 
(3.6±0.1) and detection wavelength (240±1). Their effects on tailing 
factor (T), theoretical plates and % RSD were studied.  
RESULTS AND DISCUSSION 
Linearity and range 
The linearity is a capability of the method to produce test results 
that are directly proportional to the concentration of an analyte in a 
given range as shown in fig. 2. Table 2 and 3 specify the regression 
statistics obtained from the linearity test. Fig. 3 and 4 are the blank 
and standard chromatogram. 
 
Table 2: Calibration curve of chlorthalidone enantiomer 1 and 2 
Concentration(µg/ml) Enantiomer 1 Peak area Enantiomer 2 Peak area 
2 22042 21533 
4 45782 42609 
6 69281 66906 
8 90729 88221 
10 111065 108340 
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Fig. 2: Calibration curve of chlorthalidone enantiomer 1 and enantiomer 2 
 
Table 3: Linearity data of chlorthalidone 
Parameters Enantiomer 1 Enantiomer 2 
Linearity 2-10µg/ml 2-10µg/ml 
Regression equation y=11172x+793.9 y=10961x-246 
Slope 11172 10961 
Intercept 793.9 246 
Correlation coefficient 0.998 0.999 
Retention time (tR) 5.75 min 7.46 min 
Resolution -- 2.55 
Tailing factor 0.99 1.01 
Theoretical plates 3417 3036 
 
 
Fig. 3: Blank chromatogram 
 
 
Fig. 4: Standard racemic chlorthalidone chromatogram 
 
Table 4: Assay of chlorthalidone formulation 















Fig. 5: Formulation of chlorthalidone chromatogram 
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Assay determines the potency or content of analyte present in the 
sample. Assay results are tabulated in table 4 and chromatogram 
shown in fig. 5. 
Precision 
System precision 
The system precision was carried out to ensure that the analytical 
system was working properly. The system precision is performed by 6 
sample injections and checking the reproducibility in the peak area. 
Chromatograms were recorded. The results are shown in table 5. 
Method precision  
Intraday precision 
The precision express reliability of the method, where it defines the 
extent for the individual test results can agree to repeated test result 
on same operating conditions at a short time period. Repeatability of 
the method is accepted, as % RSD of chlorthalidone enantiomer 1 and 
2 are (0.33 and 0.73) of the retention time (<1%) and % RSD of 
chlorthalidone enantiomer 1 and 2 are (0.033 and 0.029) of the peak 
areas of six replicates injection of 2, 4 and 6µg/ml (<2%) which was 
within the limits. 
Intermediate precision 
Repeatability method procedure was repeated on the next day. The 
method passed the test, as both retention time (<1%) and response 
peak areas (<2%), % RSD obtained were in the limits and was 
shown in table 6. 
System suitability studies 
System suitability test was carried out to confirm the resolution and 
reproducibility of the system on which analysis are to be done. This 
study data was summarised in table 7. All the values are well within the 
limit. 
 
Table 5: System precision of chlorthalidone enantiomers 









Average 4 45774 42608 45761 42613 
Mean SD 8.62 5.56 11.93 8.02 
Mean %RSD 0.018 0.013 0.026 0.018 
(mean±SD) n = Number of determinations, *Average of six determinants, SD=Standard deviation, RSD=Relative standard deviation 
 
Table 6: Precision study of chlorthalidone 
 Components Intraday Precision Interday Precision 
Theoretical concentration µg/ml Theoretical concentration µg/ml 
Retention time Enantiomer 1 Mean RT 5.75 5.74 5.75 5.74 5.737 5.75 
Enantiomer 1 Mean % RSD 0.33 0.28 0.38 0.36 0.31 0.43 
Enantiomer 2 Mean RT 7.48 7.47 7.46 7.46 7.51 7.45 
Enantiomer 2 Mean % RSD 0.76 0.62 0.81 0.87 0.86 0.89 
Peak area 
 
Enantiomer 1 Mean Peak area 22047 45774 69281 22042 45761 69285 
Enantiomer 1 Mean % RSD 0.072 0.018 0.0108 0.0806 0.026 0.013 
Enantiomer 2 Mean Peak area 21533 42608 66906 21532 42613 66910 
Enantiomer 2 Mean % RSD 0.062 0.013 0.013 0.0715 0.018 0.016 
(mean±SD) n = Number of determinations, *Average of six determinants, RSD=Relative standard deviation 
 
Table 7: System suitability parameters of chlorthalidone 
Parameters Enantiomer 1 Enantiomer 2 
Peak area 69282 66905 
Theoretical plates (N) 3407 3033 
Resolution -- 2.55 
Tailing factor (T) 0.99 0.992 
Capacity factor 1.4 2.1 
Asymmetric factor 1.1 1.1 
% RSD 0.38 0.81 
n = Number of determinations, *Average of six determinants 
 





















50 4 2 6 5.97 99.5 0.25 6.03 100.5 0.44 
5.95 99.17 5.99 99.83 
5.98 99.66 5.98 99.66 
Mean 99.44 Mean 99.99 
100 4 4 8 7.99 99.87 0.38 7.98 99.75 0.50 
8.03 100.37 8.05 100.62 
7.97 99.62 7.98 99.75 
Mean 99.95 Mean 100.04 
150 4 6 10 10.17 101.7 0.31 10.08 100.8 0.55 
10.03 100.3 10.03 100.3 
9.97 99.7 9.97 99.7 
Mean 100.56 Mean 100.26 
n = Number of determinations, *Average of three determinants of each concentration. 
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Recovery data of chlorthalidone enantiomers which was applied at 
three different levels (50%, 100% and 150%) of enantiomer 1 and 
enantiomer 2 were found to be 99.8% and 100.09% respectively. 
Recovery data were summarized in table 8. 
Limit of detection and limit of quantification 
The LOD of chlorthalidone enantiomer 1 and 2 results were 
summarized in table 9. 
Robustness 
Deliberate changes in organic solvent (±%), flow rate (±ml/min), 
the ionic strength of buffer (±pH) and detection wavelength 
(±nm) on experimental parameters such as tailing factor (T), 
theoretical plates and resolution of the peak were studied in 
robustness test.  
The obtained results were calculated and summarized in table 
10. 
 
Table 9: Limit of detection and limit of quantification of chlorthalidone 
Parameter Enantiomer 1 Enantiomer 2 
LOD(µg/ml) 0.086967 0.023078 
LOQ(µg/ml) 0.263536 0.069933 
 
Table 10: Robustness of chlorthalidone 
Condition Chlorthalidone Tailing factor Theoretical plates % RSD Resolution 
Optimized condition Enantiomer 1 0.99 3417 -- -- 
Enantiomer 2 1.01 3036 -- 2.55 
Mobile phase ratio 
(60:40 v/v) 
55:45 Enantiomer 1 0.987 3415 0.87 -- 
Enantiomer 2 1.004 3026 0. 98 2.48 
65:35 Enantiomer 1 0.99 3420 0.92 -- 
Enantiomer 2 1.007 3029 0. 89 2.51 
Flow rate(ml/min) 
(1.0 ml/min) 
0.9 Enantiomer 1 0.99 3419 1.002 -- 
Enantiomer 2 1.012 3033 0.96 2.5 
1.1 Enantiomer 1 0.985 3421 0.98 -- 
Enantiomer 2 1.004 3037 0.95 2.57 
pH of phosphate buffer 
(3.6) 
3.5 Enantiomer 1 0.979 3409 1.12 -- 
Enantiomer 2 1.011 3029 0.998 2.54 
3.7 Enantiomer 1 0.985 3418 1.10 -- 
Enantiomer 2 1.008 3034 1.002 2.542 
Wavelength(nm) 
(240) 
239 Enantiomer 1 0.984 3422 0.78 -- 
Enantiomer 2 1.006 3027 0.83 2.53 
241 Enantiomer 1 0.988 3411 0.96 -- 
Enantiomer 2 1.01 3038 0.98 2.5 
n = Number of determinations, *Average of three determinants. 
 
CONCLUSION 
A new RP-UFLC method was developed and validated for the 
separation of chlorthalidone enantiomers in bulk and pharmaceutical 
dosage form on a Phenomenex® Lux cellulose 4 column (250×4.6 mm, 
5µ) using disodium hydrogen phosphate buffer: methanol (40:60 v/v, 
pH 3.6). The method is fast and cost effective as both the enantiomers 
were eluted within ten min. The resolution between two peaks was 
more than 1.5. The method is accurate and precise as the %RSD of 
both interday and intraday were<2. The percentage recovery of 
chlorthalidone enantiomers was found to be 99.98% and 100.09% 
respectively. The LOD and LOQ were within the limit. From the 
discussion, it can be concluded that the proposed method is specific, 
robust, precise and accurate. This method utilizes mobile phase which 
can be effortlessly prepared and cost efficient. Results are in good 
agreement with label claim which indicates there is no interference of 
excipients. Therefore the proposed method can be used for routine 
analysis of chlorthalidone pharmaceutical dosage form. 
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